NCT03771027

Brief Summary

Diet components are important factors in pathogenesis of functional gastrointestinal disorders, especially in the irritable bowel syndrome. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) are a group of short chain, poorly absorbed and osmotically active carbohydrates, which can induce gastrointestinal symptoms because of rapid fermentation in different segments of the gut. Low FODMAP diet is a novel treatment option with proven efficacy in reducing symptoms of functional gastrointestinal disorders in adults. Conversely, although functional abdominal pain is a common health problem in children, the efficacy of a low FODMAP diet remains understudied in this population. The aim of this study was to compare the effects of two diets: a low FODMAP diet and a diet based on standard dietary advice of the National Institute for Health and Care Excellence (NICE), on abdominal symptoms in children with functional abdominal pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 8, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2017

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2018

Completed
Last Updated

December 10, 2018

Status Verified

December 1, 2018

Enrollment Period

5 months

First QC Date

December 6, 2018

Last Update Submit

December 7, 2018

Conditions

Keywords

low FODMAP dietfunctional abdominal painchildren

Outcome Measures

Primary Outcomes (1)

  • Assessment of abdominal pain severity

    Wong-Baker FACES Pain Rating Scale where 0 = no hurt and 10 = hurts worst was used for assessed severity of abdominal pain during the 6-week study period (2 weeks before and 4 weeks during the diet)

    6 weeks

Secondary Outcomes (1)

  • Assessment of abdominal pain and defecation frequency

    6 weeks

Other Outcomes (4)

  • Assessment of stool consistency

    6 weeks

  • Assessment of nutritional status

    4 months

  • Assessment of physical activity

    4 months

  • +1 more other outcomes

Study Arms (2)

Low FODMAP diet group

EXPERIMENTAL

four weeks of the low FODMAP diet based on Monash University low FODMAP diet App.

Other: The low FODMAP diet.

Control group

ACTIVE COMPARATOR

four weeks of the diet based on NICE guidelines and contained products with different FODMAP content

Other: The diet based on NICE guidelines.

Interventions

The low FODMAP group had reduced the intake of FODMAP. Children received 3 main meals and 2 snacks daily prepared by the catering company according to the Human Nutrition Recommendations for Polish Population. The dietary intervention lasted four weeks.

Low FODMAP diet group

The control group based on NICE guidelines received diet contained products with different FODMAP content. Children received 3 main meals and 2 snacks daily prepared by the catering company according to the Human Nutrition Recommendations for Polish Population. The dietary intervention lasted four weeks.

Control group

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • functional abdominal pain according to Rome III criteria
  • consent to participate in the study
  • positive decision of gastroenterologist concerning enrolment of the patient to the trial

You may not qualify if:

  • organic causes for gastrointestinal tract disorders,
  • occurrence of an abdominal migraine, IBS, food allergies or intolerances, other significant disorders, acute infection
  • antibiotic treatment within the last 8 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Regional Specialized Children's Hospital

Olsztyn, 10-561, Poland

Location

University of Warmia and Mazury

Olsztyn, 10-719, Poland

Location

Study Officials

  • Katarzyna M Boradyn, MSc

    Department of Human Nutrition, Faculty of Food Science, University of Warmia and Mazury

    PRINCIPAL INVESTIGATOR
  • Elżbieta Jarocka-Cyrta, Ph.D

    Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum Faculty of Medicine, University of Warmia and Mazury

    PRINCIPAL INVESTIGATOR
  • Katarzyna E Przybyłowicz, Ph.D

    Department of Human Nutrition, Faculty of Food Science, University of Warmia and Mazury

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 6, 2018

First Posted

December 10, 2018

Study Start

July 8, 2017

Primary Completion

December 8, 2017

Study Completion

December 8, 2017

Last Updated

December 10, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations